Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Study Protocol

Development of a multidisciplinary medication management program in nursing homes: protocol for a randomized controlled trial

Multidisciplinary medication management in nursing homes

Authors: Hye Jun Lee, Sunmee Jang, Ju-Yeun Lee, Young-Mi Ah, Mi-Kyung Lee, Suhyun Jang, Sena An, Jung-Ha Kim

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

Polypharmacy and the use of potentially inappropriate medications are common among nursing home residents and are associated with negative outcomes. Although deprescribing has been proposed as a way to curtail these problems, the best way to implement multidisciplinary comprehensive medication review and deprescribing and its real impact in specific high-risk populations, such as nursing home residents, is still unclear. This multicenter randomized controlled clinical trial aims to assess the effects of a multidisciplinary mediation management program on medication use and health problems.

Methods

A total of 1,672 residents aged ≥ 65 years from 22 nursing homes in South Korea who meet the targeted criteria, such as the use of ≥ 10 medications, are eligible to participate. The experimental group will receive a comprehensive medication review, deprescription, and multidisciplinary case conference with the help of platform. Outcomes will be measured at baseline, at the end of the intervention, as well as at 3, 6, 9, and 12 months after the end of the intervention. The primary endpoints will be the rate of adverse drug events, number of potentially inappropriate medications/potentially inappropriate medication users/two or more central nervous system drug/ central nervous system drug users, delirium, emergency department visits, hospitalization, and falls. The secondary endpoint will be the number of medications taken and polypharmacy users.

Discussion

Our trial design is unique in that it aims to introduce a structured operationalized clinical program focused on reducing polypharmacy and potentially inappropriate medications in a nursing home setting with large samples.

Trial registration

Ethical approval was granted by the public institutional review board of the Ministry of Health and Welfare (2022-1092-009). The study is also registered with the Clinical Research Information Service (Identifier: KCT0008157, Development and evaluation of a multidisciplinary medication management program in long-term care facility residents Status: Approved First Submitted Date: 2023/01/18 Registered Date: 2023/02/03 Last Updated Date: 2023/01/18 (nih.go.kr) https://​cris.​nih.​go.​kr/​), which includes all items from the World Health Organization Trial Registration Dataset.
Appendix
Available only for authorised users
Literature
2.
go back to reference Cateau D, Ballabeni P, Mena S, et al. Deprescribing in nursing homes: protocol for nested, randomised controlled hybrid trials of deprescribing interventions. Res Soc Adm Pharm. 2021;17(4):786–94.CrossRef Cateau D, Ballabeni P, Mena S, et al. Deprescribing in nursing homes: protocol for nested, randomised controlled hybrid trials of deprescribing interventions. Res Soc Adm Pharm. 2021;17(4):786–94.CrossRef
3.
go back to reference Hoffmann F, Schmiemann G, Dorks M. Assessment of polypharmacy: a question of definition and underlying data. Z Evid Fortbild Qual Gesundhwes. 2016;113:27–35.CrossRefPubMed Hoffmann F, Schmiemann G, Dorks M. Assessment of polypharmacy: a question of definition and underlying data. Z Evid Fortbild Qual Gesundhwes. 2016;113:27–35.CrossRefPubMed
4.
go back to reference Endres HG, Kaufmann-Kolle P, Steeb V, et al. Association between potentially inappropriate medication (PIM) use and risk of hospitalization in older adults: an observational study based on routine data comparing PIM use with use of PIM alternatives. PLoS One. 2016;11(2):e0146811.CrossRefPubMedPubMedCentral Endres HG, Kaufmann-Kolle P, Steeb V, et al. Association between potentially inappropriate medication (PIM) use and risk of hospitalization in older adults: an observational study based on routine data comparing PIM use with use of PIM alternatives. PLoS One. 2016;11(2):e0146811.CrossRefPubMedPubMedCentral
5.
go back to reference Kim BR, Song KH, Ahn HJ, Jung JY, Shin JS. A survey on medicine use in the elderly. J Korean Gerontol Nurs. 2001;3(2):208–16. Kim BR, Song KH, Ahn HJ, Jung JY, Shin JS. A survey on medicine use in the elderly. J Korean Gerontol Nurs. 2001;3(2):208–16.
6.
go back to reference Kim JC, Hwang SE, Chon HM, et al. Potentially inappropriate medication use in older adults living in long-term care facilities in Korea. Korean J Fam Pract. 2015;5(3):277–82. Kim JC, Hwang SE, Chon HM, et al. Potentially inappropriate medication use in older adults living in long-term care facilities in Korea. Korean J Fam Pract. 2015;5(3):277–82.
7.
go back to reference Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.CrossRefPubMed Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.CrossRefPubMed
8.
go back to reference Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254–68.CrossRefPubMedPubMedCentral Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254–68.CrossRefPubMedPubMedCentral
9.
go back to reference Mangin D, Lamarche L, Agarwal G, et al. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial. Trials. 2021;22:746.CrossRefPubMedPubMedCentral Mangin D, Lamarche L, Agarwal G, et al. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial. Trials. 2021;22:746.CrossRefPubMedPubMedCentral
10.
go back to reference Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.CrossRefPubMed Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.CrossRefPubMed
11.
go back to reference Kua CH, Mak VS, Lee SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20(3):362–72.CrossRefPubMed Kua CH, Mak VS, Lee SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20(3):362–72.CrossRefPubMed
12.
13.
go back to reference Renaudin P, Baumstarck K, Daumas A, et al. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial. Trials. 2017;18(1):65.CrossRefPubMedPubMedCentral Renaudin P, Baumstarck K, Daumas A, et al. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial. Trials. 2017;18(1):65.CrossRefPubMedPubMedCentral
14.
go back to reference Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and the effect of deprescribing in older adults on mortality and health: a systematic review. Br J Clin Pharmacol. 2016;82:583–623.CrossRefPubMedPubMedCentral Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and the effect of deprescribing in older adults on mortality and health: a systematic review. Br J Clin Pharmacol. 2016;82:583–623.CrossRefPubMedPubMedCentral
15.
go back to reference Ailabouni N, Mangin D, Nishtala PS. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41(1):167–78.CrossRefPubMed Ailabouni N, Mangin D, Nishtala PS. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41(1):167–78.CrossRefPubMed
16.
go back to reference Alldred DP, Kennedy MC, Hughes C, Chen TF, Miller P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2:CD009095.PubMed Alldred DP, Kennedy MC, Hughes C, Chen TF, Miller P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2:CD009095.PubMed
Metadata
Title
Development of a multidisciplinary medication management program in nursing homes: protocol for a randomized controlled trial
Multidisciplinary medication management in nursing homes
Authors
Hye Jun Lee
Sunmee Jang
Ju-Yeun Lee
Young-Mi Ah
Mi-Kyung Lee
Suhyun Jang
Sena An
Jung-Ha Kim
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04844-2

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine